Advice
Following an abbreviated submission
Abacavir tablets 300mg are accepted for use in a once-daily dosing regimen in NHS Scotland for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infected adults and adolescents over 12 years, in combination with other antiretroviral medicinal products.
Download detailed advice26KB (PDF)
Medicine details
- Medicine name:
- Abacavir 300mg tablets (Ziagen®)
- SMC ID:
- 174/05
- Indication:
- HIV-1
- Pharmaceutical company
- GlaxoSmithKline UK Ltd
- BNF chapter
- Infections
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 09 May 2005